DelveInsight's 'Progressive Familial Intrahepatic Cholestasis (PFIC) - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Progressive Familial Intrahepatic Cholestasis (PFIC) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Study Period: 2017-2030
The DelveInsight Progressive Familial Intrahepatic Cholestasis (PFIC) epidemiology report gives a thorough understanding of the Progressive Familial Intrahepatic Cholestasis (PFIC) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Progressive Familial Intrahepatic Cholestasis (PFIC) in the US, Europe, and Japan. The report covers the detailed information of the Progressive Familial Intrahepatic Cholestasis (PFIC) epidemiology scenario in seven major countries (US, EU5, and Japan).
The Progressive Familial Intrahepatic Cholestasis (PFIC) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Progressive Familial Intrahepatic Cholestasis (PFIC) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Progressive Familial Intrahepatic Cholestasis (PFIC) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
The Progressive Familial Intrahepatic Cholestasis (PFIC) epidemiology covered in the report provides historical as well as forecasted Progressive Familial Intrahepatic Cholestasis (PFIC) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.
The DelveInsight Progressive Familial Intrahepatic Cholestasis (PFIC) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
1. Key Insights
2. Executive Summary of Progressive Familial Intrahepatic Cholestasis (PFIC)
3. Progressive Familial Intrahepatic Cholestasis (PFIC): Disease Background and Overview
3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis
4. Patient Journey
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
5.3.1. Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology Scenario in the 7MM (2017- 2030)
5.4. United States Epidemiology
5.4.1. Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology Scenario in the United States (2017- 2030)
5.5. EU-5 Country-wise Epidemiology
5.5.1. Germany Epidemiology
5.5.1.1. Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology Scenario in Germany (2017- 2030)
5.5.2. France Epidemiology
5.5.2.1. Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology Scenario in France (2017- 2030)
5.5.3. Italy Epidemiology
5.5.3.1. Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology Scenario in Italy (2017- 2030)
5.5.4. Spain Epidemiology
5.5.4.1. Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology Scenario in Spain (2017- 2030)
5.5.5. United Kingdom Epidemiology
5.5.5.1. Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology Scenario in the United Kingdom (2017-2030)
5.6. Japan Epidemiology
5.6.1. Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology Scenario in Japan (2017- 2030)
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Progressive Familial Intrahepatic Cholestasis (PFIC) Treatment and Management
6.2. Progressive Familial Intrahepatic Cholestasis (PFIC) Treatment Algorithm
7. KOL Views
8. Unmet Needs
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
*The table of contents is not exhaustive; will be provided in the final report
Table 1 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in 7MM (2017-2030)
Table 2 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in 7MM (2017-2030)
Table 3 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in the United States (2017-2030)
Table 4 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in the United States (2017-2030)
Table 5 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in Germany (2017-2030)
Table 6 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in Germany (2017-2030)
Table 7 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in France (2017-2030)
Table 8 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in France (2017-2030)
Table 9 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in Italy (2017-2030)
Table 10 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in Italy (2017-2030)
Table 11 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in Spain (2017-2030)
Table 12 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in Spain (2017-2030)
Table 13 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in the United Kingdom (2017-2030)
Table 14 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
Table 15 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in Japan (2017-2030)
Table 16 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in Japan (2017-2030)
Figure 1 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in 7MM (2017-2030)
Figure 2 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in 7MM (2017-2030)
Figure 3 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in the United States (2017-2030)
Figure 4 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in the United States (2017-2030)
Figure 5 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in Germany (2017-2030)
Figure 6 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in Germany (2017-2030)
Figure 7 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in France (2017-2030)
Figure 8 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in France (2017-2030)
Figure 9 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in Italy (2017-2030)
Figure 10 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in Italy (2017-2030)
Figure 11 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in Spain (2017-2030)
Figure 12 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in Spain (2017-2030)
Figure 13 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in the United Kingdom (2017-2030)
Figure 14 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
Figure 15 Progressive Familial Intrahepatic Cholestasis (PFIC) Epidemiology in Japan (2017-2030)
Figure 16 Progressive Familial Intrahepatic Cholestasis (PFIC) Diagnosed and Treatable Cases in Japan (2017-2030)
*The table of contents is not exhaustive; will be provided in the final report